发明申请
US20090324575A1 LYSOSOMAL PHOSPHOLIPASE A2 (LPLA2) ACTIVITY AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR IDENTIFYING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSIS
有权
LOSOSOMAL PHOSPHOLIPASE A2（LPLA2）活性作为诊断和治疗系统性LUPUS ERYTHEMATOSISIS的诊断和治疗目标
- 专利标题： LYSOSOMAL PHOSPHOLIPASE A2 (LPLA2) ACTIVITY AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR IDENTIFYING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSIS
- 专利标题（中）： LOSOSOMAL PHOSPHOLIPASE A2（LPLA2）活性作为诊断和治疗系统性LUPUS ERYTHEMATOSISIS的诊断和治疗目标
-
申请号： US12495209申请日： 2009-06-30
-
公开(公告)号： US20090324575A1公开(公告)日： 2009-12-31
- 发明人: James A. Shayman , Akira Abe , Robert Kelly , Jessica Kollmeyer , Ye Lu
- 申请人： James A. Shayman , Akira Abe , Robert Kelly , Jessica Kollmeyer , Ye Lu
- 申请人地址： US MI Ann Arbor
- 专利权人： THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- 当前专利权人： THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- 当前专利权人地址： US MI Ann Arbor
- 主分类号： A61K38/46
- IPC分类号： A61K38/46 ; C12N5/00 ; A01K67/00 ; C12Q1/44 ; A61P37/06
摘要：
The present invention is directed to methods for diagnosis and treatment of systemic lupus erythematosus and drug-induced systemic lupus erythematosus. More specifically, the specification describes methods using a lysosomal phospholipase A2 in methods for the diagnosis and treatment of autoimmune disorders such as systemic lupus erythematosus and drug-induced systemic lupus erythematosus.